PBH — Prestige Consumer Healthcare Balance Sheet
0.000.00%
- $2.95bn
- $3.85bn
- $1.14bn
- 91
- 79
- 63
- 92
Annual balance sheet for Prestige Consumer Healthcare, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 32.3 | 27.2 | 58.5 | 46.5 | 97.9 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 115 | 139 | 167 | 177 | 194 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 270 | 293 | 392 | 375 | 448 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 103 | 98.5 | 89.5 | 89.3 | 128 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,429 | 3,671 | 3,354 | 3,318 | 3,402 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 122 | 143 | 161 | 117 | 107 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 2,071 | 2,093 | 1,907 | 1,663 | 1,567 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 1,358 | 1,578 | 1,447 | 1,655 | 1,835 |
| Total Liabilities & Shareholders' Equity | 3,429 | 3,671 | 3,354 | 3,318 | 3,402 |
| Total Common Shares Outstanding |